(Q30231576)

11 June 2017

Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection (English)

1 reference

11 June 2017

1 reference

1 reference

0 references

Lieve Naesens

3

0 references

Erik De Clercq

object named as

Erik De Clercq

7

0 references

Johan Neyts

object named as

Johan Neyts

2

0 references

Ab Osterhaus

13

object named as

Albert D M E Osterhaus

1 reference

11 June 2017

4

Geert van Amerongen

1 reference

11 June 2017

1

Koert J Stittelaar

1 reference

11 June 2017

8

Hubert G M Niesters

1 reference

11 June 2017

Rob F van Lavieren

5

1 reference

11 June 2017

Antonin Holý

6

1 reference

11 June 2017

Edwin Fries

9

1 reference

11 June 2017

Chantal Maas

10

1 reference

11 June 2017

Paul G H Mulder

11

1 reference

11 June 2017

Ben A M van der Zeijst

12

1 reference

11 June 2017

language of work or name

English

0 references

publication date

11 December 2005

1 reference

11 June 2017

1 reference

11 June 2017

439

1 reference

11 June 2017

745-748

1 reference

11 June 2017

7077

1 reference

The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis).

11 June 2017

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

Smallpox: anything to declare?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

The Confirmation and Maintenance of Smallpox Eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

Zoonotic poxvirus infections in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

US military smallpox vaccination program experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

Therapeutic potential of nucleoside/nucleotide analogues against poxvirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

Australia. Engineered mouse virus spurs bioweapon fears

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

The 'supervirus'? Lessons from IL-4-expressing poxviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

Antiviral prophylaxis of smallpox

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

Efficacy of Multiple- or Single-Dose Cidofovir against Vaccinia and Cowpox Virus Infections in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

Aerosolized cidofovir is retained in the respiratory tract and protects mice against intranasal cowpox virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

Comparative effects of cidofovir and cyclic HPMPC on lethal cowpox and vaccinia virus respiratory infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

Efficacy of cidofovir in a murine model of disseminated progressive vaccinia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

Cidofovir in the therapy and short-term prophylaxis of poxvirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

Orthopoxvirus targets for the development of antiviral therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

Gleevec casts a pox on poxviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

6-[2-phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines: a new class of acyclic pyrimidine nucleoside phosphonates with antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

Effectiveness of Postexposure Vaccination for the Prevention of Smallpox: Results of a Delphi Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

Outbreaks of disease suspected of being due to human monkeypox virus infection in the Democratic Republic of Congo in 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04295

21 January 2018

Identifiers

DOI

10.1038/NATURE04295

1 reference

Dimensions Publication ID

11 June 2017

0 references

1 reference